Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes (Q79861067)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 June 2006

Language	Label	Description	Also known as
English	Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes	scientific article published on 02 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

based on heuristic

inferred from title

3

object named as

Thomas Ebensen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

object named as

Kai Schulze

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Colleen Olive

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Carlos A Guzmán

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

2 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

35-36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

6088-6095

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Streptococcal toxic shock syndrome associated with necrotizing fasciitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Streptococcal toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Group A Streptococcal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Molecular basis of group A streptococcal virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Pathogenesis of group A streptococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Post-streptococcal acute glomerulonephritis in Chile--20 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Group A streptococci among school-aged children: clinical characteristics and the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Meta-analysis of bacterial resistance to macrolides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Clindamycin-resistant Streptococcus pyogenes: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Group A and group B streptococcal vaccine development. A round table presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Characterization of a novel fibronectin-binding surface protein in group A streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Streptococcal M protein: molecular design and biological behavior.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Group A streptococcal M proteins: virulence factors and protective antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Comparison of CTL reactivity in the spleen and draining lymph nodes after immunization with peptides pulsed on dendritic cells or mixed with Freund's incomplete adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen ofYersinia pestisusing novel delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Domain structure and conserved epitopes of Sfb protein, the fibronectin-binding adhesin of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Co-operative binding of human fibronectin to SfbI protein triggers streptococcal invasion into respiratory epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Protective Immune Response againstStreptococcus pyogenesin Mice after Intranasal Vaccination with the Fibronectin‐Binding Protein SfbI

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Serious bacterial infections in newborn infants in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Acute rheumatic fever: a chink in the chain that links the heart to the throat?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Immune response to superoxide dismutase in group A streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Epitope-vaccine strategy against HIV-1: today and tomorrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Inhibition of Bacterial Adherence by Secretory Immunoglobulin A: A Mechanism of Antigen Disposal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.024

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.05.024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828529%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79861067&oldid=1934475664"